1. Glutamine Starvation Affects Cell Cycle, Oxidative Homeostasis and Metabolism in Colorectal Cancer Cells
    Martina Spada et al, 2023, Antioxidants CrossRef
  2. Thymoquinone Selectively Kills Hypoxic Renal Cancer Cells by Suppressing HIF-1α-Mediated Glycolysis
    Yoon-Mi Lee et al, 2019, International Journal of Molecular Sciences CrossRef
  3. Anticancer Potential of Apigenin and Isovitexin with Focus on Oncogenic Metabolism in Cancer Stem Cells
    Maryam Ghanbari-Movahed et al, 2023, Metabolites CrossRef
  4. Apigenin as Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer
    Milad Ashrafizadeh et al, 2020, Frontiers in Chemistry CrossRef
  5. Pharmacologic approaches to amino acid depletion for cancer therapy
    Carly S. Wilder et al, 2022, Molecular Carcinogenesis CrossRef
  6. Green synthesized apigenin conjugated gold nanoparticles inhibit cholangiocarcinoma cell activity and endothelial cell angiogenesis in vitro
    Nipaporn Ngernyuang et al, 2022, Heliyon CrossRef
  7. The Protective Effect of Apigenin on Myocardial Injury in Diabetic Rats mediating Activation of the PPAR-γ Pathway
    Umesh Mahajan et al, 2017, International Journal of Molecular Sciences CrossRef
  8. Immunomodulatory Potential of Hedwigia ciliata and Hypnum cupressiforme
    Tanja Lunić et al, 2023, Bioactive Compounds in Bryophytes and Pteridophytes CrossRef
  9. Glutamine deprivation plus BPTES alters etoposide- and cisplatin-induced apoptosis in triple negative breast cancer cells
    Lian Chen et al, 2016, Oncotarget CrossRef
  10. Apigenin in cancer therapy: anti-cancer effects and mechanisms of action
    Xiaohui Yan et al, 2017, Cell & Bioscience CrossRef
  11. Himalayan flora: targeting various molecular pathways in lung cancer
    Abija James et al, 2023, Medical Oncology CrossRef
  12. GLS and GLS2 Glutaminase Isoenzymes in the Antioxidant System of Cancer Cells
    Juan De los Santos-Jiménez et al, 2024, Antioxidants CrossRef
  13. Phellodendrine chloride suppresses proliferation of KRAS mutated pancreatic cancer cells through inhibition of nutrients uptake via macropinocytosis
    Pyone Myat Thu et al, 2019, European Journal of Pharmacology CrossRef
  14. Expression and role of p16 and GLUT1 in malignant diseases and lung cancer: A review
    Aldo Pezzuto et al, 2020, Thoracic Cancer CrossRef
  15. Reactive oxygen species: Key players in the anticancer effects of apigenin?
    Omolola R. Oyenihi et al, 2022, Journal of Food Biochemistry CrossRef
  16. Apigenin inhibits colonic inflammation and tumorigenesis by suppressing STAT3-NF-κB signaling
    Xiao-Yu Ai et al, 2017, Oncotarget CrossRef
  17. Glucose Transport and Homeostasis in Lung Epithelia
    Deborah L. Baines et al, 2017, Lung Epithelial Biology in the Pathogenesis of Pulmonary Disease CrossRef
  18. Inhibition of Glucose Transporters and Glutaminase Synergistically Impairs Tumor Cell Growth
    Elena S. Reckzeh et al, 2019, Cell Chemical Biology CrossRef
  19. An Update on Potential Molecular Biomarkers of Dietary Phytochemicals Targeting Lung Cancer Interception and Prevention
    Rebecca Mary Peter et al, 2023, Pharmaceutical Research CrossRef
  20. Tumor cell membrane-coated continuous electrochemical sensor for GLUT1 inhibitor screening
    Jiaqian Zhao et al, 2023, Journal of Pharmaceutical Analysis CrossRef
  21. Hypoxia promotes mitochondrial glutamine metabolism through HIF1α-GDH pathway in human lung cancer cells
    Zi-Feng Jiang et al, 2017, Biochemical and Biophysical Research Communications CrossRef
  22. A comprehensive and current review on the role of flavonoids in lung cancer–Experimental and theoretical approaches
    Şeyda Berk et al, 2022, Phytomedicine CrossRef
  23. Insulin and cancer: a tangled web
    Brooks P. Leitner et al, 2022, Biochemical Journal CrossRef
  24. Integrated network pharmacology and in-silico approaches to decipher the pharmacological mechanism of Selaginella tamariscina in the treatment of non-small cell lung cancer
    Sunil Kumar et al, 2023, Phytomedicine Plus CrossRef
  25. Bioactive Natural Leads Targeting Cancer Cell Metabolism
    Prasanta Dey et al, 2021, Evidence Based Validation of Traditional Medicines CrossRef
  26. Regulation of hepatic hydroxy methyl glutarate – CoA reductase for controlling hypercholesterolemia in rats
    Abeer A. Khamis et al, 2017, Biomedicine & Pharmacotherapy CrossRef
  27. Apigenin attenuates Aluminum phosphide-induced cytotoxicity via reducing mitochondrial/Lysosomal damages and oxidative stress in rat Cardiomyocytes
    Asal Jahedsani et al, 2020, Pesticide Biochemistry and Physiology CrossRef
  28. Glutamine metabolism in cancers: Targeting the oxidative homeostasis
    Tengfang Gong et al, 2022, Frontiers in Oncology CrossRef
  29. The phenolic profile and biological activities of the wild-edible mushrooms Helvella leucopus and Morchella pulchella
    İsmail Acar et al, 2021, Journal of Food Measurement and Characterization CrossRef
  30. Recent updates on anticancer mechanisms of polyphenols
    Eshita Sharma et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
  31. Glutaminases regulate glutathione and oxidative stress in cancer
    José M. Matés et al, 2020, Archives of Toxicology CrossRef
  32. Plant Flavone Apigenin: an Emerging Anticancer Agent
    Eswar Shankar et al, 2017, Current Pharmacology Reports CrossRef
  33. Integrative Treatment of Lung Cancer Patients: Observational Study of 57 Cases
    Lorenzo Anelli et al, 2021, Asian Journal of Oncology CrossRef
  34. Can Apigenin Be an Effective Therapeutic Agent Against Experimental Renal Ischemia-Reperfusion Injury?
    Ömer Topdağı et al, 2024, Pediatric Practice and Research CrossRef
  35. Power of two: combination of therapeutic approaches involving glucose transporter (GLUT) inhibitors to combat cancer
    Kalpana Tilekar et al, 2020, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  36. Integrated network pharmacology and cellular assay reveal the biological mechanisms of Limonium sinense (Girard) Kuntze against Breast cancer
    Hualong Zhao et al, 2023, BMC Complementary Medicine and Therapies CrossRef
  37. Potential of green-synthesized selenium nanoparticles using apigenin in human breast cancer MCF-7 cells
    Aljohra M. Al-Otaibi et al, 2022, Environmental Science and Pollution Research CrossRef
  38. Role of Induced Programmed Cell Death in the Chemopreventive Potential of Apigenin
    Jung Yoon Jang et al, 2022, International Journal of Molecular Sciences CrossRef
  39. Apigenin in cancer therapy: From mechanism of action to nano-therapeutic agent
    Yun Zhou et al, 2022, Food and Chemical Toxicology CrossRef
  40. Induction of Cancer Cell Death by Apigenin: A Review on Different Cell Death Pathways
    Peyman Amini et al, 2023, Mini-Reviews in Medicinal Chemistry CrossRef
  41. Baccharis trimera phytochemicals and the mitochondria
    Ana Carolina Silveira Rabelo, 2021, Mitochondrial Physiology and Vegetal Molecules CrossRef
  42. Targeting Tumor Metabolism with Plant-Derived Natural Products: Emerging Trends in Cancer Therapy
    Angela R. Guerra et al, 2018, Journal of Agricultural and Food Chemistry CrossRef
  43. Targeting metabolism with herbal therapy: A preventative approach toward cancer
    Deepti Singh et al, 2022, Herbal Medicines CrossRef
  44. Avian and Mammalian Facilitative Glucose Transporters
    Mary Shannon Byers et al, 2017, Microarrays CrossRef
  45. 18F-FDG PET imaging for monitoring the early anti-tumor effect of albendazole on triple-negative breast cancer
    Honglian Liu et al, 2020, Breast Cancer CrossRef
  46. Immunomodulatory Potential of Hedwigia ciliata and Hypnum cupressiforme
    Tanja Lunić et al, 2023, Bioactive Compounds in Bryophytes and Pteridophytes CrossRef
  47. Apigenin as an anticancer agent
    Muhammad Imran et al, 2020, Phytotherapy Research CrossRef
  48. Chemotherapeutic Role of Polyphenols Present in Ocimum sanctum
    Saima Khatoon et al, 2022, Anti-Cancer Agents in Medicinal Chemistry CrossRef
  49. From Krebs to clinic: glutamine metabolism to cancer therapy
    Brian J. Altman et al, 2016, Nature Reviews Cancer CrossRef
  50. Phytocompounds Targeting Metabolic Reprogramming in Cancer: An Assessment of Role, Mechanisms, Pathways, and Therapeutic Relevance
    Asifa Khan et al, 2021, Journal of Agricultural and Food Chemistry CrossRef
  51. Apigenin-Loaded Stealth Liposomes: Development and Pharmacokinetic Studies for Enhanced Plasma Retention of Drug in Cancer Therapy
    Priya Shetti et al, 2024, Topics in Catalysis CrossRef
  52. Heme degradation enzyme biliverdin IXβ reductase is required for stem cell glutamine metabolism
    Zongdong Li et al, 2018, Biochemical Journal CrossRef
  53. Apigenin inhibits NF-κB and Snail signaling, EMT and metastasis in human hepatocellular carcinoma
    Yuan Qin et al, 2106, Oncotarget CrossRef
  54. Apigenin role as cell-signaling pathways modulator: implications in cancer prevention and treatment
    Zeeshan Javed et al, 2021, Cancer Cell International CrossRef
  55. Amino Acid Depletion Therapies: Starving Cancer Cells to Death
    Miriam Butler et al, 2021, Trends in Endocrinology & Metabolism CrossRef
  56. Apigenin in cancer therapy: Prevention of genomic instability and anticancer mechanisms
    Masoud Moslehi et al, 2023, Clinical and Experimental Pharmacology and Physiology CrossRef
  57. GLUT1 as a Prognostic Factor for Classical Hodgkin’s Lymphoma: Correlation with PD-L1 and PD-L2 Expression
    Young Wha Koh et al, 2017, Journal of Pathology and Translational Medicine CrossRef
  58. Apigenin: A current review on its beneficial biological activities
    Xiang Zhou et al, 2017, Journal of Food Biochemistry CrossRef
  59. The peculiarities of cancer cell metabolism: A route to metastasization and a target for therapy
    Tiago MA. Carvalho et al, 2019, European Journal of Medicinal Chemistry CrossRef
  60. PD-L1 protein expression in non-small-cell lung cancer and its relationship with the hypoxia-related signaling pathways: A study based on immunohistochemistry and RNA sequencing data
    Young Wha Koh et al, 2019, Lung Cancer CrossRef
  61. Rationalizing the therapeutic potential of apigenin against cancer
    Semim Akhtar Ahmed et al, 2021, Life Sciences CrossRef
  62. Targeting apoptosis and autophagy following spinal cord injury: Therapeutic approaches to polyphenols and candidate phytochemicals
    Fatemeh Abbaszadeh et al, 2020, Pharmacological Research CrossRef
  63. Differential expression and prognostic significance of GLUT1 according to histologic type of non-small-cell lung cancer and its association with volume-dependent parameters
    Young Wha Koh et al, 2017, Lung Cancer CrossRef
  64. Efficacy of Concanavalin-A conjugated nanotransfersomal gel of apigenin for enhanced targeted delivery of UV induced skin malignant melanoma
    Manmohan S. Jangdey et al, 2019, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
  65. Phytochemicals intended for anticancer effects at preclinical levels to clinical practice: Assessment of formulations at nanoscale for non-small cell lung cancer (NSCLC) therapy
    The Hong Phong Nguyen et al, 2021, Process Biochemistry CrossRef
  66. Apigenin Improves Hypertension and Cardiac Hypertrophy Through Modulating NADPH Oxidase-Dependent ROS Generation and Cytokines in Hypothalamic Paraventricular Nucleus
    Hong-Li Gao et al, 2021, Cardiovascular Toxicology CrossRef
  67. Metabolic Reprogramming of Cancer by Chemicals that Target Glutaminase Isoenzymes
    José M. Matés et al, 2020, Current Medicinal Chemistry CrossRef